Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms
Objectives: A mutation in the JAK2 gene, V617F, has been identified in several BCR-ABL1 negative myeloproliferative neoplasms (MPN): polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Defining the presence or absence of this mutation is an essential part of clin...
Main Authors: | Alline Didone, Luciana Nardinelli, Mariana Marchiani, Antonio Roberto Lancha Ruiz, Ariel Lais de Lima Costa, Ismael Severino Lima, Nathalia Moreira Santos, Sabri Saeed Sanabani, Israel Bendit |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-04-01
|
Series: | Practical Laboratory Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235255171530007X |
Similar Items
-
Concomitant BCR-ABL and JAK2 V617F in a patient with myeloproliferative neoplasm: a case report
by: A, Alia Suzana, et al.
Published: (2023) -
CORRELATION BETWEEN JAK2V617F MUTATIONAL BURDEN AND THE DEGREE OF ANGIOGENESIS IN THE BONE MARROW OF BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
by: Liana Gercheva, et al.
Published: (2014-09-01) -
Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination
by: Magda Zanelli, et al.
Published: (2024-01-01) -
BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
by: Aleksandra Mroczkowska-Bękarciak, et al.
Published: (2023-09-01) -
Gene aberrations and methylation analysis of JAK/stat and toll-like receptor downstream signalling in BCR-ABL-negative myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms overlap syndromes
by: Cai, Chia Yuh
Published: (2021)